Industry News

You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.

Haleon will target greater household penetration
Premium

3 March 2022

Increasing household penetration for its brands will be the “largest opportunity” for GlaxoSmithKline (GSK) Consumer Healthcare following its demerger as Haleon in July 2022, according to Brian McNamara, chief executive officer designate of Haleon.

Read the full story

Switches and naturals are high on Haleon’s agenda
Premium

3 March 2022

Switching medicines from prescription to non-prescription status and launching naturals will be high on the agenda at GlaxoSmithKline (GSK) Consumer Healthcare following its demerger as Haleon in July 2022, says Brian McNamara, chief executive officer designate of Haleon.

Read the full story

Stada welcomes German decision on doxylamine
Premium

2 March 2022

Stada has welcomed a decision by the German health ministry to allow the antihistamine doxylamine to remain available without a prescription for use by people of all ages with sleep disorders, including those aged 65 years and older.

Read the full story